Skip to main content

Table 1 Demographic information of the patients, biological sample types, sites of origin and World Health Organization (WHO) classification of NETs

From: The emerging clinical relevance of genomic profiling in neuroendocrine tumours

Patient

Material

Site of Origin

WHO Classification

P1

Liquid Biopsy

Foregut (Lung)

G1

P2

Liquid Biopsy

Foregut (Pancreas)

G2

P3

Liquid Biopsy

Foregut (Pancreas)

G3

P4

FFPE tissue

Foregut (Thymus)

G1

P5

FFPE tissue

Other (Surrenal cortical carcinoma, NET)

G3

P6

FFPE tissue

Hindgut (Rectum)

G2

P7

FFPE tissue

Foregut (Thyroid)

G1

P8

FFPE tissue

Foregut (Pancreas)

G3

P9

FFPE tissue

Other (Urinary system, NEC)

G3

P10

Peripheral Blood

Foregut (Thyroid)

G1

P11

Peripheral Blood

Foregut (Parathyroid)

G1

P12

Peripheral Blood

Foregut (Thyroid)

G1

P13

Peripheral Blood

Foregut (Pancreas)

G3

P14

Peripheral Blood

Foregut (Stomach)

G2

P15

Peripheral Blood

Other (Primary location unknown)

G3

P16

Peripheral Blood

Foregut (Thyroid)

G1

P17

Peripheral Blood

Foregut (Thyroid)

G1

P18

Peripheral Blood

Foregut (Thyroid)

G2

P19

Peripheral Blood

Foregut (Thyroid)

G1

P20

Peripheral Blood

Hindgut (Rectum)

G3

P21

Peripheral Blood

Foregut (Thyroid)

G1

P22

Peripheral Blood

Foregut (Thyroid)

G2

P23

Peripheral Blood

Foregut (Pancreas)

G3

P24

Peripheral Blood

Foregut (Pancreas)

G2

P25

Peripheral Blood

Foregut (Pancreas)

G1

P26

Peripheral Blood

Foregut (Pancreas)

G1

P27

Peripheral Blood

Foregut (Pancreas) + Hindgut (Rectum)

G3

P28

Peripheral Blood

Foregut (Pancreas)

G3

P29

Peripheral Blood

Foregut (Pancreas)

G1

P30

Peripheral Blood

Other (Primary location unknown, Hepatic and Pancreas NET)

G3

P31

Peripheral Blood

Foregut (Pancreas)

G1

P32

Peripheral Blood

Foregut (Pancreas)

G3

P33

Peripheral Blood

Foregut (Pancreas)

G1

P34

Peripheral Blood

Other (Head and Neck NET)

G3

P35

Peripheral Blood

Other (Paraganglioma, NET)

G2

  1. G Grade, NET Neuroendocrine Tumour, NEC Neuroendocrine Carcinoma. Age range in males: 17–76. Age range in females: 15–77